These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7946003)

  • 21. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG; Stebbins GT; Blasucci LM
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern treatment of Parkinson's disease.
    Pearce JM
    Br J Hosp Med; 1987 Jan; 37(1):59, 61, 64-6. PubMed ID: 3545340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical inquiry. Which drugs work best for early Parkinson's disease?
    Jain L; Benko R; Safranek S
    J Fam Pract; 2012 Feb; 61(2):106-8. PubMed ID: 22312616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa in the treatment of Parkinson's disease: current status and new developments.
    Salat D; Tolosa E
    J Parkinsons Dis; 2013 Jan; 3(3):255-69. PubMed ID: 23948989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Chen JJ; Fernandez HH
    Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly-diagnosed Parkinson's disease: a therapeutic update.
    Pleet AB
    Geriatrics; 1992 Jan; 47(1):24-9. PubMed ID: 1729144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y
    Nihon Rinsho; 1997 Jan; 55(1):65-71. PubMed ID: 9014425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimising levodopa therapy for the management of Parkinson's disease.
    Stocchi F
    J Neurol; 2005 Oct; 252 Suppl 4():IV43-IV48. PubMed ID: 16222437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse reactions to levodopa: drug toxicity or progression of disease?
    Agid Y; Chase T; Marsden D
    Lancet; 1998 Mar; 351(9106):851-2. PubMed ID: 9525359
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa.
    Okereke CS
    J Pharm Pharm Sci; 2002; 5(2):146-61. PubMed ID: 12207867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
    Verhagen Metman L
    Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early therapy for Parkinson's disease.
    Olanow CW
    Eur Neurol; 1992; 32 Suppl 1():30-5. PubMed ID: 1358615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ropinirole as compared with levodopa in Parkinson's disease.
    Hiner BC; Earnhart M
    N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684
    [No Abstract]   [Full Text] [Related]  

  • 35. New treatments for the motor symptoms of Parkinson's disease.
    Vijverman AC; Fox SH
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):761-77. PubMed ID: 25318835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies in the treatment of early Parkinson's disease.
    Rinne UK
    Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New directions in the drug treatment of Parkinson's disease.
    Montastruc JL; Rascol O; Senard JM
    Drugs Aging; 1996 Sep; 9(3):169-84. PubMed ID: 8877311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does levodopa therapy delay death in Parkinson's disease?
    Uitti RJ; Ahlskog JE; Maraganore DM
    Mov Disord; 1996 May; 11(3):343-4. PubMed ID: 8723162
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
    Pagonabarraga J; Rodríguez-Oroz MC
    Rev Neurol; 2013 Jan; 56(1):25-34. PubMed ID: 23250679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early treatment of Parkinson's disease with levodopa].
    Odekerken VJ; Post B; Verschuur CV; de Bie RM
    Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.